Zhengkang Luo

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Venues

Endocrine

International journal of molecular sciences

Biomolecules

This page only lists publications with an associated author ORCID identifier.

Publications

Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra, Bilal Safi, Martin Blixt, Stellan Sandler, Kailash Singh
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes. Endocrine 85 (2) (2024)
Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra, Bilal Safi, Martin Blixt, Stellan Sandler, Kailash Singh
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes. Endocrine 85 (2) (2024)
Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra, Bilal Safi, Martin Blixt, Stellan Sandler, Kailash Singh
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes. Endocrine 85 (2) (2024)
Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra, Bilal Safi, Martin Blixt, Stellan Sandler, Kailash Singh
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes. Endocrine 85 (2) (2024)
Zhengkang Luo, Mariela Mejia-Cordova, Nour Hamze, Elin Berggren, Saloni Chopra, Bilal Safi, Martin Blixt, Stellan Sandler, Kailash Singh
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes. Endocrine (2024)
Kailash Singh, Orian Bricard, Jeason Haughton, Mikaela Björkqvist, Moa Thorstensson, Zhengkang Luo, Loriana Mascali, Emanuela Pasciuto, Chantal Mathieu, James Dooley, Adrian Liston
Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development. Biomolecules 12 (10) (2022)
Zhengkang Luo, Charlotte Soläng, Rasmus Larsson, Kailash Singh
Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes. International journal of molecular sciences 23 (14) (2022)

Zhengkang Luo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhengkang Luo